title: The distribution of serotonin immunoreactivity in the rat locus ceruleus after intraventricular injections of either 5,6- or 5,7-dihydroxytryptamine with special reference to serotonin synthesis.
abstract: The localization of serotonin-immunoreactivity (5-HT-IR) in the locus ceruleus (LC) of rats was studied by the peroxidase-anti-peroxidase method using a purified antibody obtained from a rabbit. Antibody production was performed according to the method of Grota and Brown (1974). The antibody was applied to serial cryostat sections with alternate counterstaining by cresyl violet, after intraventricular injections of 5,6-dihydroxytryptamine or 5,7-dihydroxytryptamine prior to treatment with pargyline and a precursor of 5-HT. The majority of LC neurons were immunopositive, and more than half of all LC neurons clearly showed 5-HT-IR. Although core cells were the most predominant, all types of neurons were immunopositive, and randomly scattered throughout the LC. The uptake inhibitor, Lilly 110140, administered in sufficient amounts prior to an injection of pargyline, did not reduce 5-HT-IR within the LC. The results suggest that LC neurons receive 5-hydroxytryptophan (5-HTP) through an afferent vascular-neuronal channel and/or by diffusion from blood capillaries much more than 5-HT itself. We consider from these results that all types of LC neurons throughout the nucleus are masked 5-HT cells, and that the majority of LC neurons utilize blood-borne 5-HTP as an immediate precursor for intraneuronal 5-HT synthesis.
authors.affiliation: Department of Anatomy, School of Medicine, Akita University, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Iijima
authors.forename: K
authors.initials: K
authors.lastname: Ohtomo
authors.forename: T
authors.initials: T
authors.lastname: Ogawa
authors.forename: R
authors.initials: R
authors.lastname: Kobayashi
mesh_terms: D015115:5,6-Dihydroxytryptamine / Q000008:administration & dosage / Q000494:pharmacology*; D015116:5,7-Dihydroxytryptamine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D000906:Antibodies / Q000302:isolation & purification; D000917:Antibody Formation / Q000187:drug effects; D000918:Antibody Specificity; D002846:Chromatography, Affinity; D003429:Cross Reactions; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology; D015151:Immunoblotting; D007124:Immunoenzyme Techniques; D007276:Injections, Intraventricular; D008125:Locus Coeruleus / Q000033:anatomy & histology* / Q000276:immunology / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism*
chemical_list: D000906:Antibodies; D005473:Fluoxetine; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D010293:Pargyline; D015115:5,6-Dihydroxytryptamine